ATOX1 Promotes Hepatocellular Carcinoma Carcinogenesis via Activation of the c-Myb/PI3K/AKT Signaling Pathway
Qin Ouyang(Central South University), Jian Huang(Capital Medical University), Xiaomin Wang(Shenyang Pharmaceutical University), Siyu Jia, Hengcheng Tang(Capital Medical University), Huaduan Zi(Capital Medical University), Donghu Zhou(National Clinical Research Center for Digestive Diseases), Sisi Chen(Zhejiang Cancer Hospital), Yanling Li(Capital Medical University), Bei Zhang(Capital Medical University), Anjian Xu(Capital Medical University), Yanmeng Li(Capital Medical University), Pingping He(Wenzhou Medical University), Xiaojuan Ou(Capital Medical University), Qianyu Zhu(Tianjin Medical University)
Cited by 1
Related Papers
World Gastroenterology Organization Practice Guidelines for the Diagnosis and Management of IBD in 2010
|Inflammatory Bowel Diseases|2009|525
World Gastroenterology Organisation Global Guidelines Inflammatory Bowel Disease
|Journal of Clinical Gastroenterology|2016|232
New classification of liver biopsy assessment for fibrosis in chronic hepatitis B patients before and after treatment
|Hepatology|2016|156
Persistent Low Level of Hepatitis B Virus Promotes Fibrosis Progression During Therapy
|Clinical Gastroenterology and Hepatology|2020|115
Combination of Low Concentration of (−)-Epigallocatechin Gallate (EGCG) and Curcumin Strongly Suppresses the Growth of Non-Small Cell Lung Cancer in Vitro and in Vivo through Causing Cell Cycle Arrest
|International Journal of Molecular Sciences|2013|96